tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

CVS Stock Latest News

Prescription for Profit: 3 “Strong Buy” Healthcare Stocks Analysts Love
Stock Analysis & IdeasPrescription for Profit: 3 “Strong Buy” Healthcare Stocks Analysts Love
19m ago
CVS
ZTS
Oak Street Health downgraded to Peer Perform from Outperform at Wolfe Research
The FlyOak Street Health downgraded to Peer Perform from Outperform at Wolfe Research
3d ago
CVS
OSH
CVS Health announces quarterly dividend
Press ReleasesCVS Health announces quarterly dividend
7d ago
CVS
CVS Health put volume heavy and directionally bearish
The FlyCVS Health put volume heavy and directionally bearish
8d ago
CVS
Oak Street Health downgraded to Market Perform from Outperform at TD Cowen
The FlyOak Street Health downgraded to Market Perform from Outperform at TD Cowen
9d ago
CVS
OSH
Senate Democrats urge Walmart, Kroger, others to sell mifepristone
The FlySenate Democrats urge Walmart, Kroger, others to sell mifepristone
9d ago
ACI
CVS
Walgreens stops offer abortion pill in 21 states, face blowback, NYTimes report
The FlyWalgreens stops offer abortion pill in 21 states, face blowback, NYTimes report
16d ago
CVS
RAD
Unusually active option classes on open March 6th
The FlyUnusually active option classes on open March 6th
18d ago
CVS
AZUL
Oscar Health announces renewed agreement  with CVS Caremark
The FlyOscar Health announces renewed agreement with CVS Caremark
18d ago
CVS
OSCR
Sell these stocks now, proven algorithm says
The FlySell these stocks now, proven algorithm says
27d ago
AUR
CVS
Oak Street Health downgraded to Market Perform from Outperform at Bernstein
The FlyOak Street Health downgraded to Market Perform from Outperform at Bernstein
1M ago
CVS
OSH
Oak Street Health downgraded to Market Perform from Outperform at Raymond James
The FlyOak Street Health downgraded to Market Perform from Outperform at Raymond James
1M ago
CVS
OSH
3 Stocks to Buy Today, 2/10/2023, According to Top Analysts
Stock Analysis & Ideas3 Stocks to Buy Today, 2/10/2023, According to Top Analysts
1M ago
CVS
DHX
CVS Health price target lowered to $110 from $115 at Raymond James
The FlyCVS Health price target lowered to $110 from $115 at Raymond James
1M ago
CVS
CVS Health price target raised to $143 from $130 at Jefferies
The FlyCVS Health price target raised to $143 from $130 at Jefferies
1M ago
CVS
OSH
Oak Street Health downgraded to Hold from Buy at Jefferies
The FlyOak Street Health downgraded to Hold from Buy at Jefferies
1M ago
CVS
OSH
CVS Health price target lowered to $110 from $118 at Barclays
The FlyCVS Health price target lowered to $110 from $118 at Barclays
1M ago
CVS
CVS Health Corp Earnings Report: Is it a Beat?
Earning ReleasesCVS Health Corp Earnings Report: Is it a Beat?
1M ago
CVS
Early notable gainers among liquid option names on February 8th
The FlyEarly notable gainers among liquid option names on February 8th
1M ago
CVS
FOX
Unusually active option classes on open February 8th
The FlyUnusually active option classes on open February 8th
1M ago
AI
CVS
CVS Health says Oak Street Health deal has long term growth, earnings power
The FlyCVS Health says Oak Street Health deal has long term growth, earnings power
1M ago
CVS
OSH
CVS Health says ability to generate cash ‘remains strong’
The FlyCVS Health says ability to generate cash ‘remains strong’
1M ago
CVS
CVS Health says entering 2023 with ‘great momentum’
The FlyCVS Health says entering 2023 with ‘great momentum’
1M ago
CVS
Oak Street Health downgraded to Neutral from Overweight at Piper Sandler
The FlyOak Street Health downgraded to Neutral from Overweight at Piper Sandler
1M ago
CVS
OSH
CVS Health sees FY23 CapEx $2.8B-$3B
The FlyCVS Health sees FY23 CapEx $2.8B-$3B
1M ago
CVS
CVS Health sees FY23 Health Care Benefits revenue $101.4B-$102.9B
The FlyCVS Health sees FY23 Health Care Benefits revenue $101.4B-$102.9B
1M ago
CVS
CVS Health sees FY23 revenue $332.7B-$338.5B, consensus $325.11B
The FlyCVS Health sees FY23 revenue $332.7B-$338.5B, consensus $325.11B
1M ago
CVS
Oak Street Health downgraded to Hold from Buy at Stifel
The FlyOak Street Health downgraded to Hold from Buy at Stifel
1M ago
CVS
OSH
CVS Finally Confirms OSH Deal; Beats Q4 Expectations
Market NewsCVS Finally Confirms OSH Deal; Beats Q4 Expectations
1M ago
CVS
OSH
tipranks
TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
Find Us on
twitterstocktwitsfacebooklinkedininstagram
Newsletter SubscriptionEnter your email to receive our newsletter
iosandroid
SitemapTerms of UsePrivacy PolicyFAQ
Research ToolsTop Smart Score StocksTrending StocksDaily Stock RatingsStock ScreenerStock ComparisonAnalysts' Top StocksDaily Insider TransactionsInsiders' Hot StocksExpert Center
CalendarsEarnings CalendarDividend CalendarIPO CalendarStock Market Holidays
EducationGlossaryTipRanks Labs
PlansPlans & PricingAPI for Institutions
CompanyAbout TipRanksContact UsReviews
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.